Current issues in molecular biologyJul 28, 2026

Gene-Edited Stem Cells for Treating Blood Vessel Damage from Poor Blood Flow: Recent Progress and Future Outlook

CRISPR Gene Editing Weekly Brief ↗PubMed ↗DOI ↗OA ↗

Updated Aug 3, 2026

Abstract

Genome-editing technologies may improve stem cell therapies for vascular regeneration in ischemic disease.

Genome editing techniques can enhance the ability of stem cells to promote new blood vessel growth.
These technologies may improve stem cell survival and integration into damaged tissues.
Genetic modifications can potentially reduce the immune response against transplanted stem cells.
Enhanced stem cell functions include better resistance to oxygen deprivation and increased release of supportive factors.
Emerging concepts focus on creating universal donor cell platforms to address safety and ethical concerns.

Simplified

Ischemic vascular diseases remain a leading cause of morbidity and mortality worldwide and are frequently associated with irreversible tissue damage. Although stem cell-based therapies have shown promise for vascular regeneration, their clinical translation has been limited by poor survival, insufficient engraftment, functional heterogeneity, and immune rejection. Recent advances in genome-editing technologies, including CRISPR/Cas9, base editing, and prime editing, have provided powerful tools for overcoming these limitations through precise genetic modification of stem cells. Gene editing can enhance angiogenic potential, improve resistance to ischemic stress, augment paracrine activity, promote endothelial maturation, and reduce immunogenicity. In this review, we outline the current genome-editing toolbox and its application to stem cell engineering for vascular regeneration in ischemic disease. We also examine emerging therapeutic concepts, universal donor cell platforms, and key issues in safety and ethics, with a focus on translational pathways. Taken together, advances at the interface of genome editing and stem cell biology are likely to accelerate the development of regenerative therapies that deliver more durable vascular repair in ischemic vascular disease.

Full Text

Full text is available at the source.

View Full Text ↗

Gene-Edited Stem Cells for Treating Blood Vessel Damage from Poor Blood Flow: Recent Progress and Future Outlook

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the crispr gene editing brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the crispr gene editing brief